USD 13.3 billion
Report ID:
SQMIG35D2076 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
59
|Figures:
75
Global Cell Banking Outsourcing Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 15.59 billion in 2024 to USD 55.49 billion by 2032, growing at a CAGR of 17.2% during the forecast period (2025-2032).
The global cell banking outsourcing market is expected to experience significant growth in the coming years, driven by various factors. One of the major drivers is the rising advancement of cryopreservation and cell bank preparation methodologies. Additionally, the increasing adoption of stem cell therapies and growing demand for monoclonal antibodies and effective biopharmaceuticals contribute to market growth. According to CellTrials.org, global enrollments of new trials in advanced cell therapy increased almost 30% in the first quarter of 2020, indicating a growing demand for cell banking services. Moreover, favorable government initiatives and the introduction of new technology for cell line storage and characterization are expected to further propel market growth. Several key players in the market are involved in research collaborations, which are expected to drive market growth. For instance, in May 2021, Opsis Therapeutics, FUJIFILM Cellular Dynamics, and Blue Rock Therapeutics entered into a strategic research and development collaboration to develop off-the-shelf iPSCs to cure ocular diseases. In March 2022, a study led by the Indiana University School of Medicine found that human-induced pluripotent stem cells can improve visual acuity and vascular health, indicating the potential of stem cell banking in managing the vascular health complications associated with type 2 diabetes. Additionally, research for introducing cry protective agents to preserve tissue stability during cryopreservation is expected to drive market growth.
US Cell Banking Outsourcing Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 13.3 billion
Largest Segment
Master cell banking
Fastest Growth
Master cell banking
Growth Rate
17.2% CAGR
To get more reports on the above market click here to Buy The Report
Global Cell Banking Outsourcing Market is segmented by Type, Product, Cell Type, Phase and region. Based on Type, the market is segmented into Master Cell Banking, Viral Cell Banking and Working Cell Banking. Based on Product, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking and Embryonic Stem Cell Banking. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Phase, the market is segmented into Bank Storage, Cell Storage Stability Testing, Bank Preparation and Bank Characterization and Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
By type, the market can be segmented into master cell banking and working cell banking. Master cell banking dominated the market due to the increasing demand for the production of biopharmaceuticals and the development of stable cell lines. Master cell banking involves the creation of large quantities of cells that can be used to produce a wide range of products. The growing demand for monoclonal antibodies and effective biopharmaceuticals is driving the growth of this segment.
The working cell banking segment is expected to witness the fastest growth during the forecast period. Working cell banking involves the storage and maintenance of cells used for the production of specific products. The increasing adoption of stem cell therapies and the development of new cell line storage and characterization technology are driving the segment's growth. Additionally, the introduction of cry protective agents to preserve the stability of tissues during cryopreservation is expected to further drive the growth of the working cell banking segment.
By end-user, the market can be segmented into biopharmaceutical companies and contract research organizations (CROs). Biopharmaceutical companies dominate the market due to their large demand for cell banking services. Biopharmaceutical companies require a significant amount of cells to produce biopharmaceuticals, and outsourcing cell banking services can reduce their production costs. The increasing demand for monoclonal antibodies and effective biopharmaceuticals is driving the growth of this segment.
The CROs segment is expected to witness the fastest growth during the forecast period. Contract research organizations provide a range of services to biopharmaceutical companies, including cell banking services. The increasing outsourcing of research activities by biopharmaceutical companies to CROs is driving the growth of this segment. Additionally, the growing trend of virtual drug development is expected to further drive the growth of the CROs segment in the cell banking outsourcing market.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominated the market due to the presence of a well-established biopharmaceutical industry and advanced healthcare infrastructure. The growing demand for personalized medicines and increasing research activities in the region are driving the growth of the cell banking outsourcing market. The United States is the largest contributor to the growth of the North American market due to the increasing investments in the research and development of cell-based therapies.
The APAC region is expected to witness the fastest growth during the forecast period. The increasing demand for cell banking services in the region can be attributed to the growing awareness about the potential benefits of stem cell therapy and the increasing investment in research and development activities. Moreover, the growing population, rising prevalence of chronic diseases, and increasing healthcare expenditure are also contributing to the growth of the cell banking outsourcing market in the region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing adoption of stem cell therapies
High cost of cell banking services
Request Free Customization of this report to help us to meet your business objectives.
The global cell banking outsourcing market is highly competitive and fragmented, with several small and large players offering a wide range of services. The market players compete based on factors such as service quality, pricing, technology, and customer service. The presence of favorable government initiatives, collaborations, and strategic partnerships are also significant competitive factors in the market. Moreover, market players are focusing on the development of new technologies and services to meet the increasing demand for cell banking services. The intense competition in the market is expected to drive innovation and foster growth in the industry.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global cell banking outsourcing market analysis, the market is experiencing significant growth, driven by factors such as the increasing adoption of stem cell therapies, the growing demand for monoclonal antibodies and effective biopharmaceuticals, and the rising advancements in cryopreservation and cell bank preparation methodologies. The market is segmented by type into master cell banking and working cell banking, and by end-user into biopharmaceutical companies and contract research organizations. North America dominated the market. Key players in the market are engaging in research collaborations to develop off-the-shelf induced pluripotent stem cells (iPSCs) to cure ocular diseases and manage vascular health complications associated with type 2 diabetes.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 13.3 billion |
Market size value in 2032 | USD 55.49 billion |
Growth Rate | 17.2% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Cell Banking Outsourcing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Banking Outsourcing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Banking Outsourcing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell Banking Outsourcing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Cell Banking Outsourcing Market size was valued at USD 12.34 Billion in 2023 and is poised to grow from USD 14.36 Billion in 2024 to USD 48.4 Billion by 2032, growing at a CAGR of 16.40% during the forecast period (2025-2032).
The global cell banking outsourcing market is highly competitive and fragmented, with several small and large players offering a wide range of services. The market players compete based on factors such as service quality, pricing, technology, and customer service. The presence of favorable government initiatives, collaborations, and strategic partnerships are also significant competitive factors in the market. Moreover, market players are focusing on the development of new technologies and services to meet the increasing demand for cell banking services. The intense competition in the market is expected to drive innovation and foster growth in the industry. 'Lonza Group Ltd. (Switzerland)', 'SGS SA (Switzerland)', 'Charles River Laboratories International, Inc. (US)', 'WuXi AppTec (China)', 'Eurofins Scientific (Luxembourg)', 'Merck KGaA (Germany)', 'BioReliance Corporation (US)', 'Toxikon Corporation (US)', 'GlobalStem (US)', 'Paragon Bioservices, Inc. (US)', 'BSL Bioservice Scientific Laboratories GmbH (Germany)', 'ATCC (US)', 'BioOutsource Ltd. (UK)', 'ViruSure GmbH (Austria)', 'Sartorius AG (Germany)', 'Thermo Fisher Scientific Inc. (US)', 'Covance Inc. (US)', 'TATAA Biocenter AB (Sweden)', 'CellBank Australia (Australia)', 'StemExpress, LLC (US)'
One of the major drivers of the global cell banking outsourcing market is the increasing adoption of stem cell therapies. Stem cell therapy is a rapidly growing field of regenerative medicine that has the potential to treat a wide range of diseases and disorders. As the demand for stem cell therapies grows, the need for stable and high-quality cell lines increases, leading to a greater demand for cell banking services. This is driving the growth of the cell banking outsourcing market, as biopharmaceutical companies and CROs seek efficient and cost-effective solutions for producing and storing these valuable cell lines.
One key trend in the cell banking outsourcing market is the increasing demand for personalized medicine. Personalized medicine aims to provide individualized treatment based on a patient's genetic makeup. This requires the use of cells that are tailored to the specific needs of the patient. Cell banking outsourcing companies are investing in technologies that allow them to produce cells that are genetically matched to the patient. This trend is expected to drive the growth of the market as the demand for personalized medicine continues to increase.
North America dominated the market due to the presence of a well-established biopharmaceutical industry and advanced healthcare infrastructure. The growing demand for personalized medicines and increasing research activities in the region are driving the growth of the cell banking outsourcing market. The United States is the largest contributor to the growth of the North American market due to the increasing investments in the research and development of cell-based therapies.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35D2076
[email protected]
USA +1 351-333-4748